Table 2 Distribution of clinical characteristics among study participants
Variables | Total | Baseline (n = 241) | Follow-up (n = 160) | X2, df | p value |
|---|---|---|---|---|---|
Age | 0.909, 4 | 1.000 | |||
 31–40 | 24 (6.0) | 14 (5.8) | 10 (6.3) |  |  |
 41–50 | 76 (19.0) | 49 (20.3) | 27 (16.9) |  |  |
 51–60 | 136 (33.9) | 81 (33.6) | 55 (34.4) |  |  |
 61–70 | 118 (29.4) | 68 (28.2) | 50 (31.3) |  |  |
 71–80 | 47 (11.7) | 29 (12.0) | 18 (11.3) |  |  |
BMI | 3.386, 3 | 0.336 | |||
 Underweight | 11 (2.8) | 9 (3.80) | 2 (1.30) |  |  |
 Normal weight | 175 (43.9) | 170 (44.6) | 68 (42.8) |  |  |
 Overweight | 132 (33.10) | 80 (33.3) | 52 (32.7) |  |  |
 Obese | 81 (20.3) | 44 (18.3) | 37 (23.3) |  |  |
SBP | 0.028, 1 | 0.474 | |||
 Normal | 121 (55.1) | 132 (54.8) | 89 (55.6) |  |  |
 High | 180 (44.9) | 109 (45.2) | 71 (44.4) |  |  |
DBP | 0.178, 1 | 0.382 | |||
 Normal | 298 (74.5) | 177 (73.8) | 121 (75.6) |  |  |
 High | 102 (25.5) | 63 (26.3) | 39 (24.4) |  |  |
HbA1c | 7.280, 1 | 0.004 | |||
 Normal | 104 (26.0) | 74 (30.8) | 30 (18.8) |  |  |
 High | 296 (74.0) | 166 (69.2) | 130 (81.3) |  |  |
FPG | 0.202, 1 | 0.364 | |||
 Normal | 160 (39.9) | 94 (39.0) | 66 (41.3) |  |  |
 High | 241 (60.1) | 147 (61.0) | 94 (58.8) |  |  |
TG | 6.679, 1 | 0.006 | |||
 Good | 343 (86.2) | 199 (82.6) | 144 (91.7) |  |  |
 High | 55 (13.8) | 42 (17.4) | 13 (8.3) |  |  |
TC | 0.308, 1 | 0.328 | |||
 Good | 259 (65.2) | 154 (64.2) | 105 (66.9) |  |  |
 High | 138 (34.8) | 86 (35.8) | 52 (33.1) |  |  |
HDL | 94.80, 1 | <0.0001 | |||
 Good | 235 (59.0) | 189 (78.4) | 46 (29.3) |  |  |
 Low | 163 (41.0) | 52 (21.6) | 111 (70.7) |  |  |
NonHDL | 0.474, 1 | 0.270 | |||
 Normal | 188 (47.4) | 117 (48.8) | 71 (45.2) |  |  |
 High | 209 (52.6) | 123 (51.3) | 86 (54.8) |  |  |
LDL | 2.040, 1 | 0.092 | |||
 Good | 164 (41.3) | 106 (44.2) | 58 (36.9) |  |  |
 High | 233 (58.7) | 134 (55.8) | 99 (63.1) |  |  |
SBP (mmHg) | 140.06 ± 24.09 | 139.41 ± 24.31 | 140.71 ± 23.88 | 0.525t | 0.600 |
DBP (mmHg) | 81.96 ± 13.18 | 81.63 ± 13.71 | 82.28 ± 12.65 | 0.484t | 0.620 |
FBS (mmol/l) | 18.32 ± 4.31 | 9.18 ± 4.42 | 9.14 ± 4.20 | 0.082t | 0.940 |
HbA1c (mmol/l) | 8.79 ± 2.49 | 8.27 ± 2.10 | 9.32 ± 2.88 | 4.201t | 0.0001 |
TC (mmol/l) | 4.63 ± 1.27 | 4.73 ± 1.27 | 4.54 ± 1.27 | 1.406t | 0.160 |
TG (mmol/l) | 1.17 ± 0.56 | 1.27 ± 0.57 | 1.07 ± 0.56 | 3.520t | 0.0001 |
HDL-c (mmol/l) | 1.19 ± 1.19 | 1.35 ± 1.35 | 1.03 ± 1.03 | 9.960t | 0.0001 |
Non-HDL-c (mmol/l) | 3.44 ± 1.22 | 3.37 ± 1.24 | 3.52 ± 1.20 | 1.142t | 0.250 |
LDL-c (mmol/l) | 2.91 ± 0.57 | 2.79 ± 1.16 | 3.03 ± 1.13 | 2.029t | 0.430 |
Coronary risk | 5.00 ± 2.7 | 4.97 ± 1.52 | 5.04 ± 3.88 | 0.232t | 0.820 |
VLDL-c (mmol/l) | 0.54 ± 0.33 | 0.58 ± 0.26 | 0.51 ± 0.41 | 1.965t | 0.500 |